One-Carbon Metabolism Pathway Gene Variants and Risk of Clear Cell Renal Cell Carcinoma in a Chinese Population

被引:8
|
作者
Zhang, Lei [1 ]
Meng, Xiaoxin [1 ]
Ju, Xiaobing [1 ]
Cai, Hongzhou [1 ]
Li, Pu [1 ]
Cao, Qiang [1 ]
Shao, Pengfei [1 ]
Qin, Chao [1 ]
Yin, Changjun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 11期
基金
中国国家自然科学基金;
关键词
HARDY-WEINBERG EQUILIBRIUM; LUNG-CANCER; THYMIDYLATE-SYNTHASE; METHIONINE SYNTHASE; DNA HYPOMETHYLATION; KIDNEY CANCER; COLON-CANCER; POLYMORPHISMS; ASSOCIATION; REDUCTASE;
D O I
10.1371/journal.pone.0081129
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: One-carbon metabolism is the basement of nucleotide synthesis and the methylation of DNA linked to cancer risk. Variations in one-carbon metabolism genes are reported to affect the risk of many cancers, including renal cancer, but little knowledge about this mechanism is known in Chinese population. Methods: Each subject donated 5 mL venous blood after signing the agreement. The study was approved by the Institutional Review Board of the Nanjing Medical University, Nanjing, China. 18 SNPs in six one-carbon metabolism-related genes (CBS, MTHFR, MTR, MTRR, SHMT1, and TYMS) were genotyped in 859 clear cell renal cell carcinoma (ccRCC) patients and 1005 cancer-free controls by the Snapshot. Results: Strong associations with ccRCC risk were observed for rs706209 (P = 0.006) in CBS and rs9332 (P = 0.027) in MTRR. Compared with those carrying none variant allele, individuals carrying one or more variant alleles in these two genes had a statistically significantly decreased risk of ccRCC [P = 0.001, adjusted odds ratio (OR) = 0.73, 95% confidence interval (CI) = 0.06-0.90]. In addition, patients carrying one or more variant alleles were more likely to develop localized stage disease (P = 0.002, adjusted OR = 1.37, 95% CI = 1.11-1.69) and well-differentiated ccRCC (P, 0.001, adjusted OR = 1.42, 95% CI = 0.87-1.68). In the subgroup analysis, individuals carrying none variant allele in older group (P = 0.007, adjusted OR = 0.67, 95% CI = 0.49-0.91), male group (P = 0.007, adjusted OR = 0.71, 95% CI = 0.55-0.92), never smoking group (P = 0.002, adjusted OR = 0.68, 95% CI = 0.53-0.88) and never drinking group (P, 0.001, adjusted OR = 0.68, 95% CI = 0.53-0.88) had an increased ccRCC risk. Conclusions: Our results suggest that the polymorphisms of the one-carbon metabolism-related genes are associated with ccRCC risk in Chinese population. Future population-based prospective studies are required to confirm the results.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] EGFR, KRAS and BRAF mutations in Chinese patients with clear cell renal cell carcinoma
    Wen, Shuang
    Li, Mei
    Liu, Zhi-Min
    Liu, Li-Sha
    Tian, Can
    Shao, Xiao-Qing
    Lv, Shen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 578 - 586
  • [32] Single Nucleotide Polymorphisms of One-Carbon Metabolism and Cancers of the Esophagus, Stomach, and Liver in a Chinese Population
    Chang, Shen-Chih
    Chang, Po-Yin
    Butler, Brendan
    Goldstein, Binh Y.
    Mu, Lina
    Cai, Lin
    You, Nai-Chieh Y.
    Baecker, Aileen
    Yu, Shun-Zhang
    Heber, David
    Lu, Qing-Yi
    Li, Liming
    Greenland, Sander
    Zhang, Zuo-Feng
    PLOS ONE, 2014, 9 (10):
  • [33] The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma
    Mou, Yanhua
    Zhang, Yao
    Wu, Jinchun
    Hu, Busheng
    Zhang, Chunfang
    Duan, Chaojun
    Li, Bin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Maternal genotypes of folate/one-carbon metabolism gene variants and nonsyndromic cleft lip with or without cleft palate risk in Chile
    Inostroza, Veronica
    Salamanca, Carlos
    Recabarren, Andrea S.
    Pantoja, Roberto
    Leiva, Noemi
    Pardo, Rosa
    Suazo, Jose
    EUROPEAN JOURNAL OF ORAL SCIENCES, 2021, 129 (05)
  • [35] Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
    Moore, Lee E.
    Brennan, Paul
    Karami, Sara
    Menashe, Idan
    Berndt, Sonja I.
    Dong, Linda M.
    Meisner, Allison
    Yeager, Meredith
    Chanock, Stephen
    Colt, Joanne
    Schwartz, Kendra
    Davis, Faith
    Zaridze, David
    Mattveev, Vsevolod
    Janout, Vladimir
    Kollarova, Hellena
    Bencko, Vladimir
    Navratilova, Marie
    Szeszenia-Dabrowska, Neonilia
    Mates, Dana
    Holcatova, Ivana
    Boffetta, Paolo
    Chow, Wong-Ho
    Rosenberg, Philip S.
    Rothman, Nathaniel
    CANCER RESEARCH, 2009, 69 (20) : 8001 - 8008
  • [36] Specific Localization of Missense Mutations in the VHL Gene in Clear Cell Renal Cell Carcinoma
    Mikhailenko, D. S.
    Zhinzhilo, T. A.
    Kolpakov, A. V.
    Kekeeva, T. V.
    Strel'nikov, V. V.
    Nemtsova, M. V.
    Kushlinskii, N. E.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 465 - 468
  • [37] Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma
    Wierzbicki, Piotr M.
    Klacz, Jakub
    Rybarczyk, Agnieszka
    Slebioda, Tomasz
    Stanislawowski, Marcin
    Wronska, Agata
    Kowalczyk, Anna
    Matuszewski, Marcin
    Kmiec, Zbigniew
    TUMOR BIOLOGY, 2014, 35 (12) : 12473 - 12487
  • [38] The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
    Qi, Xiaochen
    Li, Quanlin
    Che, Xiangyu
    Wang, Qifei
    Wu, Guangzhen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Vitamin D Pathway Genes, Diet, and Risk of Renal Cell Carcinoma
    Karami, S.
    Brennan, P.
    Navratilova, M.
    Mates, D.
    Zaridze, D.
    Janout, V.
    Kollarova, H.
    Bencko, V.
    Matveev, V.
    Szesznia-Dabrowska, N.
    Holcatova, I.
    Yeager, M.
    Chanock, S.
    Rothman, N.
    Boffetta, P.
    Chow, W-H.
    Moore, L. E.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2010, 2010
  • [40] A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
    Terrematte, Patrick
    Andrade, Dhiego Souto
    Justino, Josivan
    Stransky, Beatriz
    de Araujo, Daniel Sabino A.
    Neto, Adriao D. Doria
    CANCERS, 2022, 14 (09)